CBDMEDIC Announces Partnership with Gillette Stadium and Patriot Place, Advocating CBD for Pain Relief and to promote awareness of the CBDMEDIC brand
October 25th, 2019
BOSTON, Oct. 25, 2019 /PRNewswire/ — Today, Abacus Health Products (“Abacus”), maker of CBDMEDIC, announced a partnership with Gillette Stadium and Patriot Place, revealing that CBDMEDIC branding will be present outside the stadium and throughout Patriot Place, including a new look for the iconic water tower as part of a new CBD advocacy program. The partnership is also football’s three-time world champion Rob Gronkowski’s next step as a proponent for CBD as a safe and effective solution for pain management. The news follows Gronkowski’s career announcement in August, in which he shared his personal experiences with CBDMEDIC after using its products as part of his own post-football recovery.
This first-of-its-kind collaboration between Gillette Stadium and a CBD company demonstrates the organization’s support for Rob Gronkowski’s advocacy efforts to help people everywhere understand the power of CBD to manage pain.
“CBDMEDIC helped change my life and has been a major part of my pain recovery regiment post-retirement,” said Gronkowski. “I’m passionate about sharing my recovery story and encouraging other people to experience the benefits of using CBD. Now, with this powerful promotional partnership with Gillette Stadium and Patriot Place, we hope to encourage others, especially athletes and sports enthusiasts, to try this pain management and recovery solution.”
Starting on October 27, Abacus will sample its products, including CBDMEDIC Muscle & Joint Pain Relief Ointment, to guests at Patriot Place.
“We are happy to partner with Abacus and Rob Gronkowski to use our brand and location to promote pain management alternatives to guests of Patriot Place and Gillette Stadium,” said Murray Kohl, vice president of sales for Gillette Stadium. “We look forward to working with them on initiatives that will positively impact our communities.”
“Our core mission is to help Americans in pain with science-based products that are safe and effective, and we’re delighted to have the support of Gillette Stadium and Patriot Place,” said Perry Antelman, CEO of Abacus. “We’re pleased to work together to promote CBD as a recovery solution.
To learn more about CBDMEDIC, its products and its ongoing campaign with Gronkowski, visit www.cbd-medic.com.
About Abacus Health Products
Abacus is a company engaged in the development and commercialization of over-the-counter (OTC) registered topical medications with active pharmaceutical ingredients and which contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD from Cannabis sativa L plant. Abacus’ products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending technologies developed by Abacus. Abacus’ formulations combine advanced science with organic and natural ingredients to provide safe relief. Abacus currently offers two lines of products: (i) CBD CLINIC™, marketed to the professional practitioner market, and (ii) CBDMEDIC™, marketed to the consumer market. Abacus’ products are offered across the United States and are produced by a contract manufacturer in a cGMP compliant and audited manufacturing facility.
Launched in 2019, CBDMEDIC offers a line of topical pain medications that combines naturally-derived pain-relieving pharmaceutical ingredients along with 100% natural emollients (skin softening ingredients) and essential oils, and THC-free hemp extract to create unique formulations for fast and effective relief.
About Patriot Place
Patriot Place is a shopping, dining and entertainment destination located adjacent to Gillette Stadium in Foxborough, Massachusetts. Patriot Place features large and boutique retailers, 17 casual to high-end restaurants and other nightlife venues. Among the highlights of Patriot Place are New England’s first Bass Pro Shops, a state-of-the-art, 14-screen Showcase Cinema De Lux, the award-winning Patriots Hall of Fame presented by Raytheon, the retro-style bowling alley, Splitsville Luxury Lanes, the modern gastro sports pub, CBS Sporting Club, the four-star Renaissance Boston Patriot Place Hotel and the Hilton Garden Inn Foxborough/Patriot Place. For more information, visit www.patriot-place.com, follow Patriot Place on Twitter (twitter.com/patriotplace) or like Patriot Place on Facebook (facebook.com/patriotplace).
About Gillette Stadium
Gillette Stadium, located in Foxborough, Mass., is New England’s premier sports and entertainment venue. The 65,878-seat stadium is the full-time home of the NFL’s six-time Super Bowl Champion New England Patriots, which has sold out every home game at Gillette Stadium since the venue opened in 2002. Gillette Stadium is also the home field of the New England Revolution of Major League Soccer and one of the world’s top grossing concert venues, according to Billboard and Pollstar. Other notable sporting events held at Gillette Stadium include the 2016 NHL Winter Classic, international soccer matches, NCAA athletics, professional lacrosse, motor sports and the Massachusetts high school football state championships. For more information, visit www.GilletteStadium.com or follow @GilletteStadium on Twitter, Instagram and Facebook.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.